15:27 , May 9, 2018 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: SNPs SNPs on 44 genomic loci could help predict the risk of MDD. Genome-wide association studies (GWAS) in 135,458 patients with MDD and 344,901 unaffected subjects identified associations between the disease and SNPs on...
07:00 , Aug 25, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Attention deficit hyperactivity disorder (ADHD) Astrotactin 2 (ASTN2) Genetic studies identified new genes that could help predict risk of ADHD. In 248 unrelated ADHD patients,...
07:00 , May 7, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Autism Astrotactin 2 (ASTN2); constitutive photomorphogenic 1 (RFWD2; COP1); contactin 4 (CNTN4); F-box protein 40 (FBXO40); neuroligin 1 (NLGN1); neurexin 1...